课题基金 / 基金详情

International

International
国际的
批准号:
7685026
负责人:
JEFFREY Samuel Allen STRINGER
金额:
$30.34万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-06-15 至 2014-05-31

项目摘要

项目成果

JEFFREY Samuel Allen STRINGER的其他基金

相似基金

相关文献

中文摘要
翻译
自1997年以来,国际核心(1C)一直是UAB CFAR的主要内容。随着CFAR和1C的变化, 在最后一个项目期间,1C的重点是赞比亚和赞比亚取得的显著成就。 主要通过与赞比亚传染病研究中心的直接合作, (CIDRZ)。CFAR于20世纪90年代末帮助建立了CIDRZ,其使命是为艾滋病毒提供基础设施支持 在赞比亚开展相关研究和治疗项目。在上一个供资期间,CFAR使CIDRZ能够 创建高通量临床实验室检测的实验室能力,高质量流式细胞术用于准确的CD4 这些技术包括结核病检测、病毒载量检测、结核病培养和快速诊断技术以及艾滋病毒抵抗能力。的 CFAR发挥的最重要作用是创建临床护理协议和基础设施,以支持部署 通过CIDRZ和赞比亚卫生部执行PEPFAR计划。利用这个非凡的系统, 卢萨卡的一项方案目前在46个社区诊所开展,并对165 000多名艾滋病毒感染者进行了评估, 使其中10万人接受抗逆转录病毒治疗。自1999年以来,CIDRZ团队已经评估了超过50万名孕妇, 为预防母婴传播和防止数万名婴儿感染艾滋病毒, 感染了CFAR帮助创建了适当的基础设施,以支持DAIDS赞助的网络临床试验, 标本库,用于支持卢萨卡的临床转化研究,帮助建立 赞比亚和UAB调查人员之间的双向研究和培训机会。的具体目标 下一个项目期间的1C是: 1)进一步开发CFAR/CIDRZ标本库,以便为研究者提供患者样本, 高质量的研究思路,重点是与赞比亚最相关的项目; 2)进一步开发CFAR/CIDRZ数据储存库,以便提供分析数据集和分析支持, 具有高质量研究理念的研究人员,特别关注初级研究人员和赞比亚人 调查员; 3)为伯明翰的CFAR成员提供临床和基础科学研究的双向培训, 赞比亚调查员; 4)通过支持,为CIDRZ和其他CFAR合作者提供领导和战略规划 CIDRZ科学咨询委员会 1C成功的衡量标准将是发起和支持的新方案的数量, 提交的赠款建议,包括发展赠款建议,正在进行的项目的出版物数量, 核心小组培训的赞比亚新调查员人数及其工作效率,以及其他调查员的贡献 UAB集团或中心的整体1C的努力。
英文摘要
The International Core (1C) has been a major element of the UAB CFAR since 1997. With the change in CFAR and 1C leadership in this last project period, the 1C has sharply focused on Zambia and the remarkable achievements occurring there, principally through a direct partnership with the Center for Infectious Diseases Research in Zambia (CIDRZ). The CFAR helped establish CIDRZ in the late 1990s with a mission to provide infrastructure support for HIV related research and treatment programs in Zambia. Over the last funding period, the CFAR has enabled CIDRZ to create laboratory capacity in high-through put clinical laboratory testing, high quality flow cytometry for accurate CD4 determinations, viral load testing, TB culture and rapid diagnostic techniques, and HIV resistance capabilities. The most important role CFAR has played is in creating the clinical care protocols and infrastructure to support the rollout of the PEPFAR program via CIDRZ and the Zambian Ministry of Health. Using this remarkable system, the PEPFAR program in Lusaka now operates in 46 community clinics and has evaluated over 165,000 HIV infected patients, placing over 100,000 of them on ARV treatment. The CIDRZ team, since 1999, has evaluated over 500,000 pregnant women for prevention of mother-to-child transmission and prevented tens of thousands of infants from becoming HIV infected. The CFAR helped create the proper infrastructure to support DAIDS-sponsored Network clinical trials and a specimen repository that is used to support the clinical-translational studies in Lusaka, helping to establish bidirectional research and training opportunities between Zambian and UAB investigators. The Specific Aims of the 1C for this next project period are: 1) To develop further the CFAR/CIDRZ specimen repository in order to provide patient samples to investigators with high-quality research ideas, with a focus on projects most relevant to Zambia; 2) To develop further the CFAR/CIDRZ data repository in order to provide analysis datasets and analytic support to investigators with high-quality research ideas, paying special attention to junior investigators and Zambian investigators; 3) To provide bidirectional training in clinical and basic science research for Birmingham-based CFAR Members and Zambian Investigators; 4) To provide leadership and strategic planning for CIDRZ and other CFAR collaborators in Zambia through support of the CIDRZ Scientific Advisory Committee. The measures for success for the 1C will be the number of new programs initiated and supported, numbers of new grant proposals submitted including Developmental Grant proposals, numbers of publications from ongoing projects, the number of new Zambian investigators trained by the Core and their productivity, and the contributions by other UAB groups or centers to the overall 1C effort.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A Randomized Trial of 17-Hydroxyprogesterone Caproate (17P) to Reduce Preterm Birth Among Women Receiving Antiretroviral Therapy in Pregnancy
  • 批准号:
    9360140
  • 项目类别:
  • 资助金额:
    $52.29万
  • 财政年份:
    2016
  • 负责人:
    JEFFREY Samuel Allen STRINGER
  • 依托单位:
A Randomized Trial of 17-Hydroxyprogesterone Caproate (17P) to Reduce Preterm Birth Among Women Receiving Antiretroviral Therapy in Pregnancy
  • 批准号:
    9769543
  • 项目类别:
  • 资助金额:
    $52.29万
  • 财政年份:
    2016
  • 负责人:
    JEFFREY Samuel Allen STRINGER
  • 依托单位:
A Randomized Trial of 17-Hydroxyprogesterone Caproate (17P) to Reduce Preterm Birth Among Women Receiving Antiretroviral Therapy in Pregnancy
  • 批准号:
    9271471
  • 项目类别:
  • 资助金额:
    $51.39万
  • 财政年份:
    2016
  • 负责人:
    JEFFREY Samuel Allen STRINGER
  • 依托单位:
Point-of-care virologic testing to improve outcomes of HIV-infected children
  • 批准号:
    8691716
  • 项目类别:
  • 资助金额:
    $96.06万
  • 财政年份:
    2012
  • 负责人:
    JEFFREY Samuel Allen STRINGER
  • 依托单位:
海外基金